Filing Details
- Accession Number:
- 0001305773-21-000050
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-05-18 21:21:30
- Reporting Period:
- 2021-05-14
- Accepted Time:
- 2021-05-18 21:21:30
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1305773 | Conformis Inc | CFMS | Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1481783 | A Mark Augusti | C/O Conformis, Inc. 600 Technology Park Drive Billerica MA 01821 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-05-14 | 54,552 | $0.76 | 2,151,465 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-05-17 | 7,311 | $0.80 | 2,144,154 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-05-18 | 4,781 | $0.81 | 2,139,373 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Represents the automatic sale of stock to cover the tax liability associated with the vesting of a Restricted Stock Award.
- The shares sold on this date were sold in multiple transactions. This price is the weighted average sales price per share of all shares sold on this date; the actual sale prices per share range from $0.7600-$0.7892, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- The shares sold on this date were sold in multiple transactions. This price is the weighted average sales price per share of all shares sold on this date; the actual sale prices per share range from $0.7950-$0.8000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- This sale was made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person.
Billionaire Hedge Funds
